Literature DB >> 26297206

Nanotechnology approaches for inhalation treatment of lung diseases.

Andriy Kuzmov1, Tamara Minko2.   

Abstract

Local administration of therapeutics by inhalation for treatment of lung diseases has the ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and therefore enhance the efficacy of the treatment, limit the penetration of nebulized therapeutic agent(s) into the bloodstream and consequently decrease adverse systemic side effects of the treatment. Nanotechnology allows for a further enhancement of the treatment efficiency. The present review analyzes modern therapeutic approaches of inhaled nanoscale-based pharmaceutics for the detection and treatment of various lung diseases.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Fibrosis; Gene delivery; Hypoxia; Lung cancer; Nanoparticles; Pulmonary delivery

Mesh：

Substances：

Year:  2015        PMID： 26297206     DOI： 10.1016/j.jconrel.2015.07.024

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


  61 in total

Review 1.  Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation.

Authors:  Ghazal Nabil; Ketki Bhise; Samaresh Sau; Mohamed Atef; Hossny A El-Banna; Arun K Iyer
Journal:  Drug Discov Today       Date:  2018-08-16       Impact factor: 7.851

2.  Assessing the effect of engineered nanomaterials on the environment and human health.

Authors:  Sean M Geary; Angie S Morris; Aliasger K Salem
Journal:  J Allergy Clin Immunol       Date:  2016-06-27       Impact factor: 10.793

3.  Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation.

Authors:  Mohammad Doroudian; Andrew O'Neill; Ciaran O'Reilly; Aisling Tynan; Leona Mawhinney; Aoife McElroy; Shanice S Webster; Ronan MacLoughlin; Yuri Volkov; Michelle E Armstrong; George A O'Toole; Adriele Prina-Mello; Seamas C Donnelly
Journal:  Nanomedicine (Lond)       Date:  2020-11-26       Impact factor: 5.307

4.  Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.

Authors:  Susanne R Youngren-Ortiz; David B Hill; Peter R Hoffmann; Kenneth R Morris; Edward G Barrett; M Gregory Forest; Mahavir B Chougule
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-03-09       Impact factor: 2.849

5.  New perspectives in nanotherapeutics for chronic respiratory diseases.

Authors:  Adriana Lopes da Silva; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Marcelo Marcos Morales
Journal:  Biophys Rev       Date:  2017-09-15

Review 6.  Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Authors:  Esther de Pablo; Raquel Fernández-García; María Paloma Ballesteros; Juan José Torrado; Dolores R Serrano
Journal:  Ann Transl Med       Date:  2017-11

Review 7.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

Review 8.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

Review 9.  Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.

Authors:  Abraham S Moses; Ananiya A Demessie; Olena Taratula; Tetiana Korzun; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2021-01-25       Impact factor: 13.281

10.  Multiwalled Carbon Nanotube Functionalization with High Molecular Weight Hyaluronan Significantly Reduces Pulmonary Injury.

Authors:  Salik Hussain; Zhaoxia Ji; Alexia J Taylor; Laura M DeGraff; Margaret George; Charles J Tucker; Chong Hyun Chang; Ruibin Li; James C Bonner; Stavros Garantziotis
Journal:  ACS Nano       Date:  2016-08-02       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.